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Purpose: 14–3-3 is a highly conserved, ubiquitously expressed family of proteins. At least seven mammalian isoforms
(β, ε, γ, η, θ, σ, and ζ) are known. These proteins associate with over 200 different target molecules and activate several
downstream signaling cascades involved in the regulation of metabolism, cell cycle, apoptosis, protein trafficking,
transcription, stress responses, and malignant transformations. We are interested in the role of these proteins in the
mechanisms regulating homeostasis and the pathologies of the human ocular surface. Therefore, our purpose is to
determine the expression of the 14–3-3 proteins in the human cornea, the conjunctiva, and the primary cells comprising
these tissues.
Methods: Using immunofluorescence, we determined the expression of 14–3-3 β, ε, γ, η, θ, σ, and ζ in paraffin sections
of the human cornea and conjunctiva. Using indirect immunofluorescence and western blot analysis, we also determined
the expression of these isoforms in primary corneal epithelial cells, keratocytes, endothelial cells, and primary conjunctival
epithelial cells. The expressions of these isoforms in primary epithelial and endothelial cells were compared with the same
expressions in several corneal cell lines. Western blot analysis was used to determine the presence of 14–3-3 isoforms in
the culture medium from corneal epithelial cells, cell lines, and the tear fluid.
Results: All the 14–3-3 isoforms were expressed in the corneal and conjunctival epithelia as well as primary epithelial
cells and cell lines. Expression of 14–3-3 σ was confined to epithelial cells and was secreted into the culture medium of
primary cells and cell lines. We also report for the first time that two of the secreted isoforms, 14–3-3 γ and ζ, are also
present in the human tear fluid.
Conclusions:  We  have  determined  that  all  the  mammalian  14–3-3  isoforms  are  expressed  in  the  human  cornea,
conjunctiva, and the component cells and that the 14–3-3 σ isoform was found to be epithelial cell specific. We propose
that the intracellular and extracellular presence of 14–3-3 σ suggest its involvement in the epithelia specific signaling
pathways.
The 14–3-3 (FTT, which stands for fourteen-three-three)
proteins, discovered in the central nervous system (CNS) and
cerebrospinal fluid (CSF) in 1967, make up a family of highly
conserved acidic molecules [1]. Seven mammalian isoforms
(β, γ, ε, σ, ζ, θ, and η) are known, and each is the product of a
separate gene. Although phosphorylation is not considered to
be an essential requirement for their biological activity, FTT
α, δ, and τ are the phosphorylated β, γ, and θ isoforms [2-4].
The number of eukaryotic cells and tissues in which these
proteins have been detected continues to increase, suggesting
a  ubiquitous  expression  and  function  [4].  The  biological
activity of this family of proteins is associated primarily with
homodimers,  but  the  heterodimers  are  beginning  to  be
observed and studied [5]. The FTT dimers interact with over
200 known target molecules phosphorylated at specific serine
or threonine residues, but the interactions that do not involve
phosphorylated partners have also been identified [6-10]. The
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interactions  of  FTT  proteins  with  their  partners  are
components  of  the  following  general  mechanisms:  i)
conformational change in the binding partner, ii) masking or
exposure of the functional motifs that regulate the intracellular
localization  of  partner  molecules,  and  iii)  changes  in  the
phosphorylation state or stability of the target molecules [3].
The diverse consequences of these interactions include events
associated  with  cell  cycle  control  [4,11],  metabolism  [4],
apoptosis [5], protein trafficking [4], transcription [4], stress
responses  [12],  and  malignant  transformation  [4,5,11,12].
However, this is still a relatively new and rapidly developing
field  of  study,  and  many  regulatory  signaling  pathways
involving  FTT  proteins  remain  poorly  understood  or
unknown. Most of the biological activities of FTT proteins
that  have  so  far  been  characterized  are  concerned  almost
exclusively with intracellular events. The discovery that FTT
σ isoform is secreted suggests involvement in autocrine or
paracrine  events  and  creates  interesting  possibilities  for
extracellular FTT functions [13-18].
Considering the scope of the involvement of FTT proteins
in the functions of living systems, it is not surprising that
studies cover diverse areas of interest ranging from embryonic
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2604development to cancer biology. Of particular interest in cancer
biology is the importance of FTT σ in a variety of cancers
(breast cancer [19], carcinomas of the urinary bladder [20],
ovaries  [21],  prostrate  [21],  and  salivary  glands  [22]),
suggesting  that  this  isoform  might  be  an  oncogene  [23].
Studies of the role of FTT proteins in embryonic development
have been facilitated by the knock out/knock down animal
models (murine) [24-26] or mutations in FTT genes [25]. The
mutation in FTT σ, which gives rise to the repeated epilation
(Er)  mouse,  is  lethal  in  homozygous  animals.  The
heterozygous  mice  (Er/+)  survive  and  are  a  very  useful
research tool for the characterization of DNA alterations and
the studies of global and tissue specific consequences [25].
We  are  particularly  interested  in  the  events  that  are
involved in the homeostasis, repair, and pathologies of the
cornea and conjunctiva. The epithelia in these dynamic barrier
tissues are particularly tightly regulated to achieve the balance
of cellular events that maintain proper tissue functions. The
cell  cycle  regulation  in  these  tissues  may  therefore  be
considered  a  critical  factor  that  maintains  the  appropriate
equilibrium  between  tissue  specific  proliferation  and
differentiation. A significant component of these equilibriums
is the presence of the putative stem cell compartment located
in  the  limbus  [27,28].  Numerous  intracellular  and
extracellular effectors are involved in epithelial cell cycle
regulation, but the role of FTT proteins in this context has not
been  studied.  We  here  describe  the  first  systematic  FTT
profiling of the human cornea, conjunctiva, primary cells, and
some cell lines by determining the expression of all seven
mammalian isoforms using indirect immunofluorescence and
western blot analysis. We also show that FTT σ expression is
specific for corneal and conjunctival epithelia and that FTT
σ, γ, and ζ, are secreted into the culture media of the primary
corneal and conjunctival epithelial cells and some corneal
epithelial cell lines. Furthermore, the secreted γ and ζ isoforms
were found in the human tear fluid from normal volunteers,
but FTT σ was not found.
METHODS
All samples were obtained in compliance with good clinical
practice with informed consent from the participants under
institutional review board regulations and in accordance with
the tenets of the Declaration of Helsinki.
Cell culture:
Primary  corneal  and  conjunctiva  epithelial  cells—
Epithelial sheets were obtained from Eye Bank (Lions Eye
Institute for Transplant & Research, Inc., Tampa, FL) corneas
(after removal of residual sclera and conjunctiva tissue) and
conjunctival tissue (primarily bulbar), and the primary cells
were cultured as previously described [29-31]. Briefly, donor
tissue was incubated in dispase (BD Biosciences, San Jose,
CA),  diluted  to  12  units/ml  with  calcium  free  EpiLife®
medium with human corneal growth supplement (Cascade
Biologicals, Portland, Oregon) at 4 °C for 48 h. The epithelial
sheets were removed from the stromas, dissociated into single
cell suspension, and then plated into tissue culture (TC) flasks
(75 cm2, vented). Flasks were coated with murine collagen
type IV (at a concentration of 5 μg/ml) using a cell scraper to
evenly coat the entire growth surface. The coated flasks were
air-dried under sterile conditions before use (or stored sterile
at 4 °C). The cells were cultured in serum free defined medium
(EpiLife®, Cascade, Portland, OR) until approximately 80%
confluent. The cells were then subcultured in EpiLife® by
harvesting with trypsin EDTA (Gibco, BRL, Carlsbad CA),
neutralization of proteolytic activity with trypsin inhibitor
(Sigma-Aldrich, St. Louis, MO), and plating into TC flasks
freshly coated with collagen type IV (BD Biosciences, San
Jose, CA).
Human corneal epithelial cell lines—Corneal epithelial
cell lines, SV40 [32] (a kind gift from Alcon Laboratories,
Inc.) and E6/E7 immortalized [33] (a kind gift from Dr. Vinod
S.  Mootha;  Department  of  Ophthalmology,  University  of
Texas  Southwestern  Medical  School,  Dallas,  TX),  were
thawed from frozen stock and cultured in serum free defined
media (EpiLife®, Cascade Biologicals) to 80% confluence.
The  epithelial  cells  were  subcultured  by  harvesting  with
trypsin/EDTA  (Gibco  BRL),  neutralizing  the  proteolytic
activity with trypsin inhibitor (Sigma-Aldrich), and plating
into freshly collagen IV coated TC flasks (BD Biosciences).
Corneal  stroma  fibroblasts—The  epithelium  was
removed from the donor corneas as described above, and the
residual  endothelium  was  peeled  off  with  Descemet’s
membrane. The denuded stromas were minced into 2 mm
cubes, which were allowed to adhere to TC flasks (or six well
TC plates). To these pieces, medium DMEM (Gibco BRL)
containing 10% fetal bovine serum (FBS; Atlanta Biologicals,
Lawrenceville,  GA)  was  then  carefully  added.  When  the
outgrowth of the corneal fibroblasts (keratocytes) was evident
(within a week from set up), the pieces were removed and the
culture process continued. The cells were subcultured into
fresh TC flasks as needed.
Corneal  endothelial  cells—Primary  endothelial  cells
were  cultured  as  previously  described  [34].  Briefly,  the
Descemet’s membrane bearing endothelial cells was removed
from  donor  corneas  and  the  whole  endothelial  explants
cultured  in  DMEM  containing  10%  FBS.  The  E6/E7
transformed endothelial cells were thawed from frozen stock
and cultured in DMEM supplemented with 10% FBS.
Immunocytochemistry: Approximately 15,000 cells were
plated  on  glass  coverslips  (12  cm2,  Thermofisher;  Fisher
Scientific, Pittsburgh, PA) and cultured in their respective
media. When the cultures had stabilized, the coverslips were
rinsed in PBS and fixed/permeabilized in methanol:acetone
(1:1) for 10 min at −20 °C. After rehydration in phosphate
buffered  saline  (PBS;  0.256  g/l  NaH2PO4  H2O,  1.19  g/l
Na2HPO4, 8.76 g/l NaCl, pH 7.4) for 30 min and three distilled
water washes, the cells were blocked overnight at 4 °C in PBS
+1% bovine serum albumin (BSA). The cells were then rinsed
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at 4 °C overnight with primary (1°) antibody diluted in PBS.
After rinsing three times 10 min each (3X 10 min) in PBS
containing  Tween-20  (0.1%),  cells  were  incubated  with
secondary (2°) antibody at room temperature (RT) for 1.5 h
and  rinsed  in  PBS+Tween-20  (0.1%,  3X  10  min).  The
specimens were rinsed in PBS (3X 10 min), distilled water for
30 min, stained with 4’,6-diamino-2-phenylindole (DAPI),
and mounted on glass slides (FluorSave™; Calbiochem, La
Jolla, CA).
Immunohistochemistry: Donor corneas and conjunctiva
were fixed in 4% formaldehyde at 4 °C for 24 h, dehydrated
through  a  series  of  ethanol  and  xylene  incubations,  and
embedded  in  paraffin.  Embedded  tissues  were  sectioned
(~10μ  thickness),  and  sections  were  deparaffinized  by
incubations in xylene and ethanol. After rehydration for 30
min  in  PBS,  distilled  water  washes  (3X),  and  blocking
overnight  at  4  °C  in  PBS+1%  BSA+1%  horse  serum,
specimens were rinsed with PBS and distilled water (3X) and
incubated with 1° antibody at 4 °C overnight. After rinsing in
PBS  (3X  10  min)  containing  0.1%  Tween-20,  the  tissue
sections were incubated with 2° antibody at RT for 1 h and
rinsed in PBS+0.1% Tween-20 (3X 10 min). The specimens
were rinsed in PBS (3X 10 min) and distilled water (1X 10
min), and glass slides were mounted on the sections after
DAPI staining (FluorSave™, Calbiochem).
Antibodies: Commercially available anti-FTT primary
antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA), which were directed to either the NH2– or
COOH-terminus or an internal epitope, and were used in the
dilution  recommended  by  the  supplier.  One  anti-FTT  σ
antibody  was  from  LabVision  (Freemont,  CA)  and  was
directed against an unknown epitope. Alexa Fluor 594 nm
goat anti-mouse, Alexa Fluor 594 nm goat-anti-rabbit, and
Alexa Fluor 594 nm donkey anti-goat (Molecular Probes/
Invitrogen, San Diego, CA) secondary antibodies were used
at dilutions of 1:1,000. Negative controls in all experiments
were specimens labeled with 2° antibody only and DAPI to
show  the  nuclei;  these  showed  virtually  no  background
fluorescence.
Image acquisition: Mounted specimens were examined
on Olympus AX70 fluorescent microscope (Olympus, Center
Valley,  PA)  using  SPOT®  TWAIN  software  (Microsoft,
Issaquah, WA).
Western blot analysis: Cultured cells, whole epithelia
sheets, and endothelial cells were treated with lysis buffer (2.5
ml 1 M Tris buffer [pH=7.0], 1 g SDS, and 2.5 g sucrose in
50 ml distilled water) for 5 min at RT. Genomic DNA was
sheared by several passes through a 22 gauge needle, and
samples  were  stored  at  –20  °C  until  needed.  BCA
(bicinchoninic acid) protein assays (Pierce, Rockford, IL) of
lysates were performed to determine the protein concentration
and  to  ensure  equal  loading  of  lanes.  SDS-PAGE  was
performed at RT, and 20 μg protein/lane were loaded with
12% Tris-glycine at 150 V with Tris/glycine as the running
buffer.  Protein  bands  were  transferred  onto  nitrocellulose
membranes  (VWR  International,  Irving,  TX)  by
electroblotting overnight (4 °C) at 10 V in Tris/glycine buffer
with 20% methanol and confirming the transfer with Ponceau
Red staining (Sigma-Aldrich) of the membranes. After de-
staining  in  distilled  water,  membranes  were  incubated  in
blocking buffer (5% powdered milk and 1% BSA in PBS) for
1 h at RT. Membranes were then incubated with 1° antibody
for 30 min at RT and then overnight at 4 °C, and they were
incubated again the following morning for 30 min at RT. After
rinsing in PBS containing 0.1% Tween-20 (3X 10 min), the
membranes were incubated with 2° antibody for 1 h at RT,
rinsed  in  PBS  with  0.1%  Tween-20  (3X  10  min),  and
developed  (ECL  Chemiluminescence;  Amersham
Biosciences, Little Chalfont, England).
Tear fluid collection: Tear washes were collected from
three normal subjects as previously described [35,36]. The
samples  were  obtained  in  compliance  with  good  clinical
practice, with informed consent under institutional review
board regulations, and in accordance with the tenets of the
Declaration of Helsinki. Sterile saline was instilled onto the
donor ocular surface. Subjects were then asked to move their
eyes  without  blinking,  and  tears  were  collected  using  a
micropipette.  Cellular  debris  was  then  removed  by
centrifugation.  Approximately  20  μg  of  protein  was  then
loaded directly onto the SDS-PAGE gel for electrophoresis
and subsequent western blot analysis.
Detection  of  secreted  14-3-3  isoforms:  Conditioned
medium from primary corneal and conjunctival epithelia cells,
as well as E6/E7 and SV40 transformed corneal epithelial cells
was collected after 48 h of culture. The conditioned medium
was centrifuged to remove any cellular debris. Strataclean®
resin (Stratagene, La Jola, CA) was used to pull down protein
from  the  conditioned  medium  as  per  the  manufacturer’s
instructions. Briefly, after the addition of 1 μl/ml resin, the
conditioned medium was centrifuged at 10,000 rpm to pellet
the resin. The resin was then re-suspended in 10 μl of sample
loading buffer. The samples were then loaded directly onto
the  SDS-PAGE  gel  for  electrophoresis  and  subsequent
western blot analysis.
RESULTS
Expression of FTT isoforms in the tissue sections of human
cornea  and  conjunctiva:  Using  commercially  available
antibodies directed against FTT β, ε, γ, η, θ, σ, and ζ, the tissue
sections  of  paraffin  embedded  human  corneas  and
conjunctivas (3 sections from 3 donors for each tissue) and
the  qualitative  expression  of  all  FTT  isoforms  was
determined.  Six  FTT  isoforms  (θ,  γ,  η,  β,  ζ,  and  ε)  are
expressed  throughout  the  central  cornea  and  the  limbus
(Figure 1A,C,D-G). However, the expression of FTT σ is
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appears strongly expressed in the superficial layers of the
central  corneal  epithelium  and  the  superficial/suprabasal
limbus epithelium. FTT β, γ, and η appear strongly expressed
in the superficial layers in the central corneal epithelium and
uniformly  expressed  throughout  the  limbus  epithelium
Figure 1. Expression of 14-3-3 proteins
in the human cornea. Panels A-H show
that  all  the  14-3-3  isoforms  are
expressed  in  the  cornea  while  the
14-3-3σ  isoform  is  restricted  to  the
epithelium. Comparison of expression
of  14-3-3  isoforms  in  the  primary
corneal cells with that in cell lines as
determined by western blot analyses of
whole cell lysates. Strong expression of
14-3-3 β, η, ε and σ is shown in the
primary corneal epithelial cells (I), E6/
E7 transformed corneal epithelia cells
(J),  and  SV40  transformed  corneal
epithelia cells (K). The expression of
14-3-3 θ is barely detectable in primary
corneal  epithelial  cells  (I)  and  but  is
present  in  the  E6/E7  and  SV40
transformed  cells  (J  and  K).  The
expression of 14-3-3 γ is very weak in
the three cell types (I, J, and K).
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2607(Figure  1A,E,F).  FTT  ε  and  ζ  are  uniformly  expressed
throughout the central cornea and the limbus epithelia (Figure
1C,G). FTT θ is uniformly expressed in all the epithelial cell
layers (Figure 1D). All seven FTT isoforms are expressed in
the human conjunctiva, and FTT σ is only expressed in the
conjunctival  epithelium  (Figure  2).  There  was  also  no
significant donor-to-donor variability (n=3) in the samples
that were used in the study.
Expression of FTT isoforms in the primary cells of the cornea
and corneal cell lines and primary conjunctival epithelial
cells: We then examined the expression of FTT proteins in
cultured primary cells of the cornea and conjunctiva and two
human corneal epithelial cell lines. The results of western blot
analyses (shown in Figure 1I-K and Figure 3) were quantified
and  summarized  in  Table  1.  The  results  of  the
immunocytochemical  analysis  are  shown  in  Figure  4  and
Figure 5. All of the FTT isoforms are expressed in the primary
corneal  and  conjunctival  epithelial  cells.  The  corneal
epithelial cells immortalized by E6/E7 and SV40 transfection
expressed all seven FTT isoforms at varying levels (Figure 1I-
K and Table 1). FTT ζ expression is high in the primary
corneal epithelial cells and the cell lines, but the expression
of FTT γ is very low. FTT θ expression is higher in both
transformed corneal epithelial cell lines than in the primary
cells.  Primary  corneal  stroma  fibroblasts  (keratocytes)
express all FTT isoforms except FTT σ, and FTT β is weakly
expressed while FTT η is barely detectable (Figure 3, Table
1). Primary corneal endothelial cells express all FTT isoforms
except FTT σ. FTT θ expression is low (Figure 3, Table 1) in
primary and E6/E7 transformed corneal endothelial cells. The
Figure 2. Expression of 14-3-3 proteins in the cross-sections of the conjunctival whole tissue as determined by indirect immunofluoresence.
The panels show that all the 14-3-3 isoforms are expressed in the cornea while the 14-3-3 σ isoform is restricted to the epithelium.
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primary cells. The conjunctival epithelial cells express all
seven FTT isoforms, but FTT ζ expression is barely detectable
(Figure 3, Table 1).
FTT isoforms secreted by cultured corneal and conjunctival
epithelial cells: Corneal and conjunctival epithelial cells when
cultured in the serum free defined medium (EpiLife) were
shown to secrete FTT σ, γ, and ζ into the culture medium
(Figure 6A). Western blot analysis was used to show that
transformed corneal epithelial cells also secrete these three
FTT isoforms. EpiLife culture medium was used as a negative
control.
Presence of FTT isoforms in the human tear fluid: We then
examined tear fluid from normal volunteers for the presence
of the FTT isoforms that were shown to be secreted into the
culture medium of corneal and conjunctival epithelial cells.
Western  blot  analysis  of  tear  samples  from  three  donors
showed that while FTT γ and ζ isoforms were present, the FTT
σ was absent from the tear fluid (Figure 6C).
DISCUSSION
We have been interested for some time in the human ocular
surface  tissue  [37-40].  The  diversity  of  cellular  events,
specifically the balance between the cell cycle regulation and
differentiation/stratification of the self-renewing epithelia, is
Figure 3. Comparison of the expression of 14-3-3 isoforms in the primary corneal and conjunctival cells with that in cell lines as determined
by western blot analyses of whole cell lysates. All the isoforms are expressed in the primary conjunctial epithelial cells but the 14-3-3 ζ is
expressed weakly (A). Primary corneal stromal fibroblasts express all the 14-3-3 isoforms but the expression of η isoform is low, and σ isoform
is not expressed (B). The primary corneal endothelial cells express all 14-3-3 isoforms except σ and θ is barely detectable (C). The E6/E7
transformed corneal endothelial cells express all the 14-3-3 isoforms more robustly than the primary cells, the expression of θ isoform is more
evident and there is no expression of σ isoform (D).
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TABLE 1. EXPRESSION OF 14–3-3 ISOFORMS IN THE CELLS OF THE OCULAR SURFACE.
FTT
isoforms
  Corneal epithelial cells
Conjunctival
   epithelial
 cells (Wt)
 
Corneal
stroma
fibroblasts
 (Wt)
 
Corneal
endothelial cells
Wt E6/E7            SV- 40                                                                                             Wt E6/E7
σ ++ ++ ++ ++ - - -
β ++ ++ ++ ++ + + ++
γ + + + ++ + + ++
θ + ++ ++ + + + +
ζ ++ ++ ++ + + + +
η + + + + + + +
ε ++ ++ ++ + + + ++
Expression levels as determined by western blot analysis. Densitometric value (after normalization) of 0.5 or greater is
symbolized  by “++” (very high expression). A value less than 0.5 is denoted as “+” (moderate expression), and value of 0 is
represented as “-” (little or no expression). Antibodies were purchased from Santa Cruz Biotechnology: 14–3-3 σ (sc-7381,
antibody directed against an epitope in the NH2-terminus and sc-7683 directed against an epitope in the COOH-terminus were
both used individually); 14–3-3 β (sc-629, antibody directed against epitope in the NH2-terminus); 14–3-3 γ (sc-731 antibody
directed against epitope in the COOH-terminus); 14–3-3 θ (sc-732 antibody directed against epitope in the COOH-terminus),
14–3-3 ζ (sc-1019 antibody directed against epitope in the internal sequences), 14–3-3 η (sc-17286 antibody directed against
epitope in the internal sequences), and 14–3-3 ε (sc-1021 antibody directed against epitope in the internal sequences).a  feature  in  their  homeostasis  and  repair.  We  therefore
consider  that  the  diverse  biological  activities  of  the  FTT
family of proteins may play a significant role in the human
cornea and conjunctiva. While studying protein expression in
corneal dystrophies, the presence of 14–3-3 σ in the corneal
epithelium has been reported [18]. For the first time, our
results show that all the FTT isoforms are expressed in the
cornea and conjunctiva but that the expression of FTT σ, also
known  as  stratifin  (Sfn),  is  confined  to  the  differentiated
superficial layers of the corneal epithelium. This correlates
well  with  the  expression  of  stratifin  in  the  epidermis,  a
stratified epithelium of the skin [41-43]. Although this FTT
isoform is proposed to be associated with differentiation, its
presence and distribution in the stratified epithelia other than
skin has not been studied and its role in differentiation has not
been established.
The abrogation of FTT σ in primary keratinocytes has
lead to immortalization [39,40], and its expression is reduced
in some cancers [20,21,44] but upregulated in others [45-47].
To begin a detailed study of this proposed relationship with
cell cycle control, we compared the expression profile of all
the isoforms in the primary corneal epithelial cells with that
in two immortalized cell lines in which the cell cycle arrest
has been altered by E6/E7 and SV40 transduction (see Table
1).  In  this  context,  SV40  and  E6/E7  immortalized  cells
showed levels of expression of all seven isoforms (including
FTT σ) similar to those determined for primary cells, with the
exception of the low levels of FTT γ expression, from western
Figure 4. The expression of 14-3-3 proteins in the cultured primary corneal epithelial cells as determined by indirect immunofluorescence.
The panels show that all the 14-3-3 isoforms are expressed in the cultured primary corneal epithelial cells.
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was FTT θ. It was barely detectable in the primary cells but
expressed robustly by both the corneal epithelial cell lines.
This FTT isoform has been proposed to be involved in nuclear
localization of telomerase [48], which is inactive in all somatic
cells,  particularly  as  they  enter  senescence.  Endogenous
expression  and  activity  of  human  telomerase  reverse
transcriptase (hTERT) has been detected in most cancer cells,
and  its  ectopic  activity  has  been  shown  to  extend  the
proliferative in vitro life span when constitutively expressed
in several types of somatic human cells [49-53]. We show a
low expression of FTT θ in the primary corneal endothelial
cells, which are not particularly mitotic in spite of having long
telomeres [54]. The antibody to FTT θ [55] and the DNA
fragments  of  the  FTT  σ  promoter  region  [56]  have  been
detected in the blood of newly diagnosed lung cancer patients
and breast cancer patients, respectively, suggesting a link with
cell  cycle  dysregulation.  The  role  of  FTT  σ  in  corneal
epithelial homeostasis appears to be more complex than its
role in the differentiation of keratinocytes and the homeostasis
and pathologies of the epidermis.
We also determined the expression of FTT proteins in
conjunctival tissue. Consistent with the expression profile
shown in the cornea, all the FTT isoforms were expressed in
the epithelium and stroma of the conjunctiva, and FTT σ
expression was once again confined to the epithelium. In
contrast to the strong expression of FTT ζ in primary corneal
epithelial cells, a low expression of this isoform was evident
in  primary  conjunctival  epithelial  cells  (Figure  3).  This
apparent  “differential”  expression,  based  on  quantified
western blot analyses of cultured cell lysates, suggests that the
interaction  of  FTT  isoforms  with  epithelial  proliferation/
Figure 5. The expression of 14-3-3 proteins in the cultured primary conjunctival epithelial cells as determined by indirect immunofluorescence.
The panels show that all the 14-3-3 isoforms are expressed in the cultured primary conjunctival epithelial cells.
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2611Figure 6. Western blot analysis of the
conditioned medium from the corneal
epithelia cells and cell lines and human
tear fluid. The primary corneal epithelial
cells were shown to secrete 14-3-3 σ, ζ,
and γ in to the condition medium (A).
E6/E7 and SV 40 transformed corneal
epithelial cells and primary conjunctival
epithelial cells also secrete these three
isoforms (B, C, and  D, respectively).
The  human  tear  fluid  from  normal
human volunteers shows the presence of
14-3-3 η and γ isoforms but sigma is
absent (H, I, and J). E, F, and G are
derived form a Ponceau Red stained blot
to show protein loading. The molecular
weight ladder is seen in L.
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2612differentiation machinery may exhibit some epithelial tissue
preference. We therefore suggest that while FTT ζ may be
preferentially expressed by the corneal epithelium, FTT γ
expression is characteristic of the conjunctival epithelium. In
contrast  to  the  qualitative  immunofluorescence  data  that
represent in vivo status, quantified western blot analyses of
cell  lysates  may  reflect  the  influence  of  the  in  vitro
environment. Lack of access to SV40 and E6/E7 immortalized
conjunctival epithelial cell lines prevented us from comparing
the FTT expression profile in primary conjunctival epithelial
cells (e.g., low expression of FTT ζ isoform) with that in
hyperproliferative cell lines. It was more difficult to precisely
assign  distribution  of  isoform  expression  within  the
conjunctival epithelium because we had no information about
tissue orientation of the eye bank tissue.
It has also been shown that FTT σ is secreted in the culture
medium during propagation of an SV40 immortalized corneal
cell line [18]. We show for the first time that primary corneal
and  conjunctival  epithelial  cells  and  E6/E7  and  SV40
immortalized corneal epithelial cells secrete FTT σ as well
FTT γ and ζ isoforms when cultured in a serum free defined
medium. Although the intracellular functions of FTT proteins
are beginning to be better understood, the role of secreted
isoforms  is  mostly  obscure.  It  has  been  shown  that
recombinant  FTT  σ  upregulates  secretion  of  matrix
metalloproteinases  (MMPs)  by  normal  human  dermal
fibroblasts  [57]  and  that  the  exosomal  export  is  a  minor
component of the overall secretion mechanisms [57]. The
extracellular function of FTT γ and ζ isoforms, the major
export mechanisms of FTT σ from the secreting cells, and the
mechanism of import into and the nature of interaction of the
secreted proteins with the target cells are not known [15]. The
functions of MMPs in tissue homeostasis are regulated by the
appropriate  tissue  inhibitors  of  matrix  metalloproteinases
(TIMPs). This equilibrium is altered after injury and during
disease  processes  where  matrix  degradation  and
reorganization  (remodeling)  are  likely  to  take  place  [58].
Since injuries to the ocular surface increase signaling events
that  control  the  responses  and  “cross-talk”  between  the
epithelium and the stroma, it is likely that the excreted FTT
isoforms play a more important role during the wound healing/
tissue repair process.
The  interaction  of  the  epithelia  with  the  tear  film
compartment  is  also  important  in  the  homeostasis  of  the
corneal and conjunctival epithelia. The cells of all the anterior
segment tissues contribute to the tear film composition while
the tear fluid components combine to protect the epithelia
from  microbial  and  chemical  insults  and  help  maintain
epithelial  barrier  structure  and  functions.  Therefore,  we
examined  the  human  tear  fluid  for  the  presence  of  FTT
isoforms, which we found to be secreted into the condition
medium in vitro. Although FTT σ could not be detected, FTT
γ and ζ isoforms were present. Since the primary conjunctival
epithelial cells express “preferentially” FTT γ while FTT ζ is
preferentially  expressed  by  the  primary  corneal  epithelial
cells, we speculate that γ and ζ isoforms are secreted by the
conjunctival  and  corneal  epithelia,  respectively.  FTT  σ  is
expressed abundantly in the superficial layers of the corneal
and conjunctival epithelium. Since it is absent from the tear
fluid, it is unlikely that the presence of FTT γ and ζ is due to
the lysis of corneal and conjunctival epithelial cells.
We report here the expression and distribution of all the
FTT  isoforms  in  the  human  cornea  and  conjunctiva.  Of
particular interest is the expression specificity of FTT σ in the
corneal  and  the  conjunctival  epithelia  and  its  potential
association with the epithelial cell differentiation. We have
also shown the presence of FTT proteins in the corneal and
conjunctival primary cells and corneal cell lines and report the
secretion  of  three  isoforms  (σ,  γ,  and  ζ)  by  the  primary
epithelial  cells  and  cell  lines.  Interestingly,  of  the  three
secreted isoforms, only FTT γ and ζ were found to be present
in tear fluid from healthy human donors. We have also shown
low expression of FTT θ in the primary corneal epithelial cells
when compared with the cell lines and note the preferential
expression of FTT γ and FTT ζ in the primary corneal and
conjunctival cells, respectively. In studying the functional
implications of the above observation, we are particularly
interested in the functional roles of the secreted isoforms
found in the tear fluid. Taken together, our results show the
presence and support the importance of the FTT family of
proteins in the tissues of the human ocular surface and indicate
the need for a better understanding of their function in the
ocular surface homeostasis and repair.
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